These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34242840)

  • 1. Hypermetabolic pulmonary lesions on FDG-PET/CT: Tularemia or neoplasia?
    Martinet P; Khatchatourian L; Saidani N; Fangous MS; Goulon D; Lesecq L; Le Gall F; Guerpillon B; Corre R; Bizien N; Talarmin JP
    Infect Dis Now; 2021 Oct; 51(7):607-613. PubMed ID: 34242840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A tularemia mimicking lymphoma].
    Chevalier K; Venon MD; Émile JF; Cabral D; Siméon S; Trichet M; Rouveix É; Hanslik T; Coutte L
    Rev Med Interne; 2020 Sep; 41(9):632-636. PubMed ID: 32359978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mediastinal lymphadenopathy: Do not forget tularemia!].
    Tissot N; Noureddine S; Guion-Dusserre M; Soumagne T
    Rev Mal Respir; 2021 Feb; 38(2):204-209. PubMed ID: 33581986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary tularaemia: all that looks like cancer is not necessarily cancer - case report of four consecutive cases.
    Fachinger P; Tini GM; Grobholz R; Gambazzi F; Fankhauser H; Irani S
    BMC Pulm Med; 2015 Mar; 15():27. PubMed ID: 25887439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary mucosa-associated lymphoid tissue lymphoma:
    Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
    Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
    Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
    HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].
    Niu X; Hu H; Gao J; Nie Y; Zhao W; Xu H; Bai X; Chen L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):502-6. PubMed ID: 25262690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
    Lobrano MB; Hayman E; Dekelbaum M; Campeau R
    J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of
    So A; Pointon O; Hodgson R; Burgess J
    Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
    Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
    J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.
    Toba H; Kondo K; Otsuka H; Takizawa H; Kenzaki K; Sakiyama S; Tangoku A
    J Med Invest; 2010 Aug; 57(3-4):305-13. PubMed ID: 20847531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
    Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK
    Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT.
    Kim KY; Park HL; Kang HS; Lee HY; Yoo IR; Lee SH; Yeo CD
    In Vivo; 2021; 35(3):1829-1836. PubMed ID: 33910869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
    Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
    J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
    Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
    Collaud S; Lardinois D; Tischler V; Steinert HC; Stahel R; Weder W
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.